[{"address1": "201 Lomas Santa Fe Drive", "address2": "Suite 300", "city": "Solana Beach", "state": "CA", "zip": "92075", "country": "United States", "phone": "858 925 7000", "website": "https://www.lenz-tx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Evert B. Schimmelpennink", "age": 52, "title": "President, CEO, Secretary & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 1071375, "exercisedValue": 0, "unexercisedValue": 13849629}, {"maxAge": 1, "name": "Mr. James W. McCollum", "age": 69, "title": "Co-Founder & Director", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 31209, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel R. Chevallard CPA", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 680368, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc G. Odrich M.D.", "age": 65, "title": "Chief Medical Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 732250, "exercisedValue": 0, "unexercisedValue": 663919}, {"maxAge": 1, "name": "Mr. Domenick  Porfidia", "title": "Vice President of Sales", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Choromanski", "title": "Vice President of Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shawn  Olsson", "age": 41, "title": "Chief Commercial Officer", "yearBorn": 1983, "fiscalYear": 2024, "totalPay": 532133, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melissa  Rosness", "title": "Senior Vice President of Manufacturing Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Kris  Gambelin", "title": "Senior Vice President of Regulatory & Clincal Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 24.5, "open": 24.66, "dayLow": 15.7, "dayHigh": 24.76, "regularMarketPreviousClose": 24.5, "regularMarketOpen": 24.66, "regularMarketDayLow": 15.7, "regularMarketDayHigh": 24.76, "payoutRatio": 0.0, "forwardPE": -6.422398, "volume": 6591770, "regularMarketVolume": 6591770, "averageVolume": 1006536, "averageVolume10days": 690800, "averageDailyVolume10Day": 690800, "bid": 18.02, "ask": 18.23, "bidSize": 3, "askSize": 2, "marketCap": 567600000, "fiftyTwoWeekLow": 15.7, "fiftyTwoWeekHigh": 50.4, "allTimeHigh": 238.0, "allTimeLow": 11.13, "priceToSalesTrailing12Months": 32.434284, "fiftyDayAverage": 31.9174, "twoHundredDayAverage": 31.219925, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 366382048, "profitMargins": 0.0, "floatShares": 20052177, "sharesOutstanding": 31289969, "sharesShort": 7959225, "sharesShortPriorMonth": 7229614, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.2544, "heldPercentInsiders": 0.02525, "heldPercentInstitutions": 0.96592003, "shortRatio": 6.53, "shortPercentOfFloat": 0.438, "impliedSharesOutstanding": 31289969, "bookValue": 6.783, "priceToBook": 2.6743329, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -58883000, "trailingEps": -2.06, "forwardEps": -2.82449, "lastSplitFactor": "1:7", "lastSplitDate": 1711065600, "enterpriseToRevenue": 20.936, "enterpriseToEbitda": -5.412, "52WeekChange": -0.20583469, "SandP52WeekChange": 0.13613915, "lastDividendValue": 7.21, "lastDividendDate": 1711065600, "quoteType": "EQUITY", "currentPrice": 18.14, "targetHighPrice": 62.0, "targetLowPrice": 36.0, "targetMeanPrice": 53.5, "targetMedianPrice": 54.0, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 202172000, "totalCashPerShare": 6.461, "ebitda": -67695000, "totalDebt": 954000, "quickRatio": 12.458, "currentRatio": 12.687, "totalRevenue": 17500000, "debtToEquity": 0.492, "revenuePerShare": 0.627, "returnOnAssets": -0.19524, "returnOnEquity": -0.28779, "grossProfits": 17500000, "freeCashflow": -25161500, "operatingCashflow": -45223000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -1.51096, "financialCurrency": "USD", "symbol": "LENZ", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_370131860", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -25.9592, "regularMarketPrice": 18.14, "shortName": "LENZ Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1765587521, "regularMarketTime": 1765573202, "postMarketChangePercent": 3.087108, "postMarketPrice": 18.7, "postMarketChange": 0.5600014, "regularMarketChange": -6.36, "regularMarketDayRange": "15.7 - 24.76", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1006536, "fiftyTwoWeekLowChange": 2.4399996, "fiftyTwoWeekLowChangePercent": 0.15541399, "fiftyTwoWeekRange": "15.7 - 50.4", "fiftyTwoWeekHighChange": -32.260002, "fiftyTwoWeekHighChangePercent": -0.6400794, "fiftyTwoWeekChangePercent": -20.58347, "dividendDate": 1710979200, "longName": "LENZ Therapeutics, Inc.", "marketState": "CLOSED", "fiftyDayAverageChange": -13.777401, "fiftyDayAverageChangePercent": -0.431658, "twoHundredDayAverageChange": -13.079926, "twoHundredDayAverageChangePercent": -0.41896084, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "earningsTimestamp": 1762349400, "earningsTimestampStart": 1762349400, "earningsTimestampEnd": 1762349400, "earningsCallTimestampStart": 1762349400, "earningsCallTimestampEnd": 1762349400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.06, "epsForward": -2.82449, "epsCurrentYear": -2.5756, "priceEpsCurrentYear": -7.0430193, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1624627800000, "displayName": "LENZ Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-13"}]